1. Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in people aged 20–64 years: cohort study using a primary care database. BMC Med. 2018; 16. [https://www.ncbi.nlm.nih.gov/pubmed/29514662]
2. Sharma T, Guski LS, Freund N, Gøtzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 2016;i65. [https://www.bmj.com/content/352/bmj.i65]
3. Zivin K, Kim HM, Yosef M, Maust DT, Valenstein M, Smith EG, et al. Antidepressant Medication Treatment and Risk of Death. J. Clin. Psychopharmacol. 2016;36:445–52. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010024/]
4. Maslej MM, Bolker BM, Russell MJ, Eaton K, Durisko Z, Hollon SD, et al. The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis. Psychother. Psychosom. 2017;86:268–82. [https://www.ncbi.nlm.nih.gov/pubmed/28903117]
5. Nelson JC, Spyker DA. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. Am. J. Psychiatry 2017;174:438–50. [https://www.ncbi.nlm.nih.gov/pubmed/28135844]
6. Andrews PW, Thomson JA, Amstadter A, Neale MC. Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front. Psychol. 2012;3:117. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334530/]
7. Andrews PW, Bharwani A, Lee KR, Fox M, Thomson JA. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neurosci. Biobehav. Rev. 2015;51:164–88. [https://www.ncbi.nlm.nih.gov/pubmed/25625874]
8. Wang S-M, Han C, Bahk W-M, Lee S-J, Patkar AA, Masand PS, et al. Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review. Chonnam Med. J. 2018;54:101–12. [https://www.ncbi.nlm.nih.gov/pubmed/29854675]
9. Katsi V, Marketou M, Vamvakou G, Makris T, Tousoulis D, Stefanadis C, et al. Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease. Recent Patents Cardiovasc. Drug Discov. 2013;8:178–85. [https://www.ncbi.nlm.nih.gov/pubmed/24712681]
10. Dhar AK, Barton DA. Depression and the Link with Cardiovascular Disease. Front. Psychiatry [Internet] 2016 [cited 2019 May 16];7. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800172/]
11. Nezafati MH, Vojdanparast M, Nezafati P. Antidepressants and cardiovascular adverse events: A narrative review. ARYA Atheroscler. 2015;11:295–304. [https://www.ncbi.nlm.nih.gov/pubmed/26715935]